Sign In
Buy ORGS
$0.590
+0.0950 (+19.19%)
At Close: Jun 03, 2026
Automakers, Tire Manufacturers Announce Plant Closures In Mexico
12:00am, Wednesday, 25'th Mar 2020
The coronavirus pandemic has caused a sharp drop-off in demand for tires and cars, causing manufacturers across North and South America to furlough workers and implement partial...
Mar 12, 2020 (The Expresswire) --
Report Title : Global Rose Essential Oil Market Professional Survey Report 2020 “Rose Essential Oil” Market Report 2020...
Avid Bioservices (CDMO) Q3 2020 Earnings Snapshot; fiscal 2020 outlook | AlphaStreet
08:17pm, Tuesday, 10'th Mar 2020
For fiscal 2020, Avid Bioservices reduced its revenue outlook to a range of $55 million to $59 million CDMO shares plummeted more than 15% during the after-hours.
While we achieved strong company-wide revenue growth, more importantly, we generated $3.1 million in sales through our newly launched POCare platform. In 2019, we signed collaborations with several l
What Kind Of Share Price Volatility Should You Expect For Orgenesis Inc. (NASDAQ:ORGS)?
07:46pm, Monday, 09'th Mar 2020
If you own shares in Orgenesis Inc. (NASDAQ:ORGS) then it's worth thinking about how it contributes to the volatility...
Orgenesis Inc. (ORGS), a provider of point-of-care cell and gene therapy development, processing and treatment solutions (“POCare”), today announced that it has entered into a collaboration agreem
Orgenesis Completes Sale of Masthercell Subsidiary; Receives Approximately $127 Million in Net Proceeds
01:00pm, Tuesday, 11'th Feb 2020
Orgenesis Inc. (ORGS), a provider of point-of-care cell and gene therapy development, processing and treatment solutions (“POCare”), today announced the completion of the sale of its Masthercell G
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
12:51pm, Tuesday, 04'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Bioscie
Catalent Buys Cell Therapy Company MaSTherCell Global, For $315M | FinSMEs
04:14pm, Monday, 03'rd Feb 2020
Catalent, Inc. (NYSE: CTLT), a Somerset, N.J.-based provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health produ
GERMANTOWN, Md., Feb. 03, 2020 -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), today announced that Catalent Pharma Solutions has agreed to acquire Masthercell.
Xconomy: Discovery Labs Converts ex-GSK King of Prussia Site into R&D "Colony"
11:00am, Monday, 03'rd Feb 2020
The MLP Ventures-funded Discovery Labs says it is “bending the rules” in its efforts to stimulate R&D at the former GlaxoSmithKline site through a
Uber had been in talks to sell Indian food delivery unit for $400M, FT reports UBER
02:02pm, Tuesday, 21'st Jan 2020
Uber had been in talks to sell Indian food delivery unit for $400M, FT reports UBER
GlaxoSmithKline: FDA grants priority review of BLA for belantamab mafodotin GSK
02:02pm, Tuesday, 21'st Jan 2020
GlaxoSmithKline: FDA grants priority review of BLA for belantamab mafodotin GSK
Avnet downgraded to Sell from Hold at Cross Research AVT
02:00pm, Tuesday, 21'st Jan 2020
Avnet downgraded to Sell from Hold at Cross Research Cross Research AVT
AMD shares 'in a bubble phase,' says Northland AMD
02:00pm, Tuesday, 21'st Jan 2020
AMD shares 'in a bubble phase,' says Northland Northland AMD
